Obviously we don't know whether they are planning to license PI-88 for individual cancers or a package - but if they are seeking to license individually as you point out they have completed Phase II Efficacy endpoint for Multiple Myeloma, which although is not a major cancer in the scheme of things - about 1% of all cancers, is still a major disease with about 13,000 people diagnosed in the UsA alone each year.
http://www.nci.nih.gov/cancer_information/doc_wyntk.aspx?viewid=5db34eef-d9c1-47dd-94e1-3c98099798ba
- Forums
- ASX - By Stock
- PGL
- drug pi-88, melanoma; how good is it?
drug pi-88, melanoma; how good is it?, page-4
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PGL (ASX) to my watchlist
|
|||||
Last
44.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.30M |
Open | High | Low | Value | Volume |
44.5¢ | 44.5¢ | 44.5¢ | $52.23K | 117.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 309406 | 44.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
45.0¢ | 301248 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 367109 | 0.445 |
8 | 914031 | 0.440 |
3 | 8500 | 0.350 |
1 | 2500 | 0.200 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.450 | 328751 | 12 |
0.460 | 100000 | 1 |
0.490 | 21811 | 2 |
0.500 | 2000 | 1 |
0.000 | 0 | 0 |
Last trade - 10.50am 24/07/2024 (20 minute delay) ? |
Featured News
PGL (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
Previous Video
Next Video
SPONSORED BY The Market Online